Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Pedro-Botet

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2017
Is a national registry of dyslipidaemia necessary?Juan Pedro-Botet
Medicina Clinica|April 17, 2007
[From children's cholesterol to cholesterol's children]Juan Pedro-Botet
Medicina Clinica|February 13, 2009
[Clinical importance of therapeutic modulation on small and dense LDL particles]Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 10, 2019
LDL-cholesterol: The lower the betterJuan Pedro-Botet, Xavier Pintó
Clinical and Translational Gastroenterology|August 9, 2020
The Forgotten Gastrointestinal Tract in COVID-19 InfectionJuan Pedro-Botet, Elisenda Climent
Endocrinologia, Diabetes Y Nutricion|November 7, 2021
Cost-effectiveness evaluation of the use of PCSK9 inhibitorsFernando Civeira, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 19, 2023
A step forward in the consensus on lipid profile characteristics for cardiovascular preventionXavier Pintó, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 9, 2017
[A glow in the secondary prevention of cardiovascular disease]Juan Pedro-Botet, Elisenda Climent
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
[PCSK9: Structure and function. PCSK9 and low-density lipoprotein receptor. Mutations and their effects]Juan Pedro-Botet, Lina Badimón
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 15, 2015
[An updated overview of the high intensity lipid lowering therapy in high cardiovascular risk patients]Juan Pedro-Botet, Xavier Pintó
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2017
Is a national registry of dyslipidaemia necessary?Juan Pedro-Botet
Medicina Clinica|April 17, 2007
[From children's cholesterol to cholesterol's children]Juan Pedro-Botet
Medicina Clinica|February 13, 2009
[Clinical importance of therapeutic modulation on small and dense LDL particles]Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 10, 2019
LDL-cholesterol: The lower the betterJuan Pedro-Botet, Xavier Pintó
Clinical and Translational Gastroenterology|August 9, 2020
The Forgotten Gastrointestinal Tract in COVID-19 InfectionJuan Pedro-Botet, Elisenda Climent
Endocrinologia, Diabetes Y Nutricion|November 7, 2021
Cost-effectiveness evaluation of the use of PCSK9 inhibitorsFernando Civeira, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 19, 2023
A step forward in the consensus on lipid profile characteristics for cardiovascular preventionXavier Pintó, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|February 9, 2017
[A glow in the secondary prevention of cardiovascular disease]Juan Pedro-Botet, Elisenda Climent
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
[PCSK9: Structure and function. PCSK9 and low-density lipoprotein receptor. Mutations and their effects]Juan Pedro-Botet, Lina Badimón
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 15, 2015
[An updated overview of the high intensity lipid lowering therapy in high cardiovascular risk patients]Juan Pedro-Botet, Xavier Pintó
Pageof 24